<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36159208</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19.</ArticleTitle><Pagination><StartPage>100513</StartPage><MedlinePgn>100513</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2022.100513</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="UNASSIGNED">Long-term cognitive performance data in former critically ill COVID-19 patients are sparse. Current evidence suggests that cognitive decline is related to neuroinflammation, which might be attenuated by COVID-19 related anti-inflammatory therapies. The objective of this prospective cohort study was to study long term cognitive outcomes following severe COVID-19 and the relation to anti-inflammatory therapies.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Prospective observational cohort of patients that survived an intensive care unit (ICU) admission due to severe COVID-19. Six months after hospital discharge, we extensively assessed both objective cognitive functioning and subjective cognitive complaints. Furthermore, patients were stratified in cohorts according to their anti-inflammatory treatment (i.e. no immunomodulatory therapy, dexamethasone, or both dexamethasone and interleukin-6 receptor antagonist tocilizumab).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">96 patients were included (March 2020-June 2021, median [IQR] age 61 [55-69] years). 91% received invasive mechanical ventilation, and mean&#xa0;&#xb1;&#xa0;SD severity-of-disease APACHE-II-score at admission was 15.8&#xa0;&#xb1;&#xa0;4.1. After 6.5&#xa0;&#xb1;&#xa0;1.3 months, 27% of patients scored cognitively impaired. Patients that did or did not develop cognitive impairments were similar in ICU-admission parameters, clinical course and delirium incidence. Patients with subjective cognitive complaints (20%) were more likely women (61% vs 26%), and had a shorter ICU stay (median [IQR] 8 [5-15] vs 18 [9-31], p&#xa0;=&#xa0;0.002). Objective cognitive dysfunction did not correlate with subjective cognitive dysfunction. 27% of the participants received dexamethasone during intensive care admission, 44% received additional tocilizumab and 29% received neither. Overall occurrence and severity of cognitive dysfunction were not affected by anti-inflammatory therapy, although patients treated with both dexamethasone and tocilizumab had worse executive functioning scores (Trail Making Test interference) than patients without anti-inflammatory treatment (T-score 40.3&#xa0;&#xb1;&#xa0;13.5 vs 49.1&#xa0;&#xb1;&#xa0;9.3, p&#xa0;=&#xa0;0.007).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">A relevant proportion of critically ill COVID-19 patients shows deficits in long-term cognitive functioning. Apart from more pronounced executive dysfunction, overall, anti-inflammatory therapy appeared not to affect long-term cognitive performance. Our findings provide insight in long-term cognitive outcomes in patients who survived COVID-19, that may facilitate health-care providers counseling patients and their caregivers.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duindam</LastName><ForeName>Harmke B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Department of Intensive Care Medicine, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kessels</LastName><ForeName>Roy P C</ForeName><Initials>RPC</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Department of Medical Psychology, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vincent van Gogh Institute for Psychiatry, Venray, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Borst</LastName><ForeName>Bram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Department of Pulmonary Diseases, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickkers</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Department of Intensive Care Medicine, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdo</LastName><ForeName>Wilson F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Radboud University Medical Center, Department of Intensive Care Medicine, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Immunomodulatory therapy</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">Respiratory distress syndrome</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest related to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>17</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36159208</ArticleId><ArticleId IdType="pmc">PMC9482799</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2022.100513</ArticleId><ArticleId IdType="pii">S2666-3546(22)00103-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alemanno F., Houdayer E., Parma A., et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Amruta N., Chastain W.H., Paz M., et al. Cytokine Growth Factor Rev; 2021. SARS-CoV-2 Mediated Neuroinflammation and the Impact of COVID-19 in Neurological Disorders; pp. 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894219</ArticleId><ArticleId IdType="pubmed">33674185</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D., Sharshar T. Cognitive decline after sepsis. Lancet Respir. Med. 2015;3:61&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">25434614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ards Definition Task Force. Ranieri V.M., Rubenfeld G.D., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Balash Y., Mordechovich M., Shabtai H., Giladi N., Gurevich T., Korczyn A.D. Subjective memory complaints in elders: depression, anxiety, or cognitive decline? Acta Neurol. Scand. 2013;127:344&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">23215819</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello T., Sayana P., Giridharan V.V., et al. Long-term cognitive outcomes after sepsis: a translational systematic review. Mol. Neurobiol. 2019;56:186&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">29687346</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaud V., Crottaz-Herbette S., Dunet V., et al. Pattern of cognitive deficits in severe COVID-19. J. Neurol. Neurosurg. Psychiatry. 2021;92:567&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053331</ArticleId><ArticleId IdType="pubmed">33219042</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker J.H., Lin J.J., Doernberg M., et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw. Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon K., Day G.S., Powers H.R., et al. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage. BMC Neurol. 2022;22:285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9338515</ArticleId><ArticleId IdType="pubmed">35907815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowie C.R., Harvey P.D. Administration and interpretation of the Trail making test. Nat. Protoc. 2006;1:2277&#x2013;2281.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradburn S., Murgatroyd C., Ray N. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: a meta-analysis. Ageing Res. Rev. 2019;50:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30610927</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent D.E., Cooper P.F., FitzGerald P., Parkes K.R. The cognitive failures questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 1982;21:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne C., Coetzer R., Addy K. Investigating the discrepancy between subjective and objective cognitive impairment following acquired brain injury: the role of psychological affect. NeuroRehabilitation. 2017;41:501&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pubmed">29036842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X.Z., Ma H., Wang J.K., et al. Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2010;34:1426&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">20691747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng G., Huang C., Deng H., Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 2012;42:484&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">22372522</ArticleId></ArticleIdList></Reference><Reference><Citation>Church S., Rogers E., Rockwood K., Theou O. A scoping review of the clinical frailty scale. BMC Geriatr. 2020;20:393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540438</ArticleId><ArticleId IdType="pubmed">33028215</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vent N.R., Agelink van Rentergem J.A., Schmand B.A., Murre J.M.J., AC, Huizenga H.M. Advanced neuropsychological diagnostics infrastructure (ANDI): a normative database created from control datasets. Front. Psychol. 2016;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5071354</ArticleId><ArticleId IdType="pubmed">27812340</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich J., Rao K., Pastorino S., Kesari S. Corticosteroids in brain cancer patients: benefits and pitfalls. Expet Rev. Clin. Pharmacol. 2011;4:233&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3109638</ArticleId><ArticleId IdType="pubmed">21666852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU) Crit. Care Med. 2001;29:1370&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445689</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo-Braga M., Cornaby C., Cortez A., et al. Influence of biological therapeutics, cytokines, and disease activity on depression in rheumatoid arthritis. J Immunol Res. 2018 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083532</ArticleId><ArticleId IdType="pubmed">30148175</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer C.E., Jiang D., Schweizer T.A. Determining the association of medical co-morbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review. BMC Geriatr. 2010;10:89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014958</ArticleId><ArticleId IdType="pubmed">21167038</ArticleId></ArticleIdList></Reference><Reference><Citation>Girgis R.R., Ciarleglio A., Choo T., et al. A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology. 2018;43:1317&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5916349</ArticleId><ArticleId IdType="pubmed">29090685</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouraud C., Bottemanne H., Lahlou-Laforet K., et al. Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID-19 episode: a cross-sectional study. Front. Psychiatr. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446522</ArticleId><ArticleId IdType="pubmed">34539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A.R., Spencer-Segal J.L. Glucocorticoids and the brain after critical illness. Endocrinology. 2021:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846201</ArticleId><ArticleId IdType="pubmed">33508121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins R.O., Weaver L.K., Collingridge D., Parkinson R.B., Chan K.J., Orme J.F., Jr. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2005;171:340&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">15542793</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators R.-C., Gordon A.C., Mouncey P.R., et al. Interleukin-6 receptor antagonists in critically ill patients with covid-19. N. Engl. J. Med. 2021;384:1491&#x2013;1502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna T.J., Ely E.W., Smith D.M., Langa K.M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787&#x2013;1794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jak A.J., Bondi M.W., Delano-Wood L., et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am. J. Geriatr. Psychiatr. 2009;17:368&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743175</ArticleId><ArticleId IdType="pubmed">19390294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungwirth S., Fischer P., Weissgram S., Kirchmeyr W., Bauer P., Tragl K.H. Subjective memory complaints and objective memory impairment in the Vienna-Transdanube aging community. J. Am. Geriatr. Soc. 2004;52:263&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">14728638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessels R.P.C., Molleman P.W., Oosterman J.M. Assessment of working-memory deficits in patients with mild cognitive impairment and Alzheimer's dementia using Wechsler's Working Memory Index. Aging Clin. Exp. Res. 2011;23:487&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">22526081</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessels R.P.C., de Vent N.R., Bruijnen C., et al. Regression-based normative data for the montreal cognitive assessment (MoCA) and its memory index score (MoCA-MIS) for individuals aged 18-91. J. Clin. Med. 2022:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9318507</ArticleId><ArticleId IdType="pubmed">35887823</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985;13:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.M., Costanzo E.S., Singh S., et al. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Transl. Psychiatry. 2021;11:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7812704</ArticleId><ArticleId IdType="pubmed">33462203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lani J.A., Derogatis L.R. BSI); 2010. Brief Symptom Inventory.</Citation></Reference><Reference><Citation>Lee D.W., Gardner R., Porter D.L., et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093680</ArticleId><ArticleId IdType="pubmed">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Rodriguez A.B., Hennessy E., Murray C.L., et al. Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL-1&#x3b2; drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement. 2021;17:1735&#x2013;1755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8874214</ArticleId><ArticleId IdType="pubmed">34080771</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., L&#xfc;tgehetmann M., Hagel C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C.L., Skelly D.T., Cunningham C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1&#x3b2; and IL-6. J. Neuroinflammation. 2011;8:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119173</ArticleId><ArticleId IdType="pubmed">21586125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bedirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Natu M.V., Agarwal A.K. Digit letter substitution test (DLST) as an alternative to digit symbol substitution test (DSST) Hum. Psychopharmacol. Clin. Exp. 1995;10:339&#x2013;343.</Citation></Reference><Reference><Citation>Nelson H.E., O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex. 1978;14:234&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">679704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto N., Terao K., Mima T., Nakahara H., Takagi N., Kakehi T. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood. 2008;112:3959&#x2013;3964.</Citation><ArticleIdList><ArticleId IdType="pubmed">18784373</ArticleId></ArticleIdList></Reference><Reference><Citation>Partington J.E., Leiter R.G. Partington's pathways test. Psychol. Service Center J. 1949;1:11&#x2013;20.</Citation></Reference><Reference><Citation>Peters van Ton A.M., Meijer-van Leijsen E.M.C., Bergkamp M.I., et al. Risk of dementia and structural brain changes following nonneurological infections during 9-year follow-up. Crit. Care Med. 2022;50:554&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">34432713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistarini C., Fiabane E., Houdayer E., Vassallo C., Manera M.R., Alemanno F. Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Front. Neurol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8165252</ArticleId><ArticleId IdType="pubmed">34079511</ArticleId></ArticleIdList></Reference><Reference><Citation>Recovery Collaborative Group. Horby P., Lim W.S., et al. Dexamethasone in hospitalized patients with covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan R.M. Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Mot. Skills. 1958:271&#x2013;276.</Citation></Reference><Reference><Citation>Schurink B., Roos E., Radonic T., et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1:e290&#x2013;e299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A., Okulla T., Sastre M., Dumitrescu-Ozimek L., Heneka M.T. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J. Chem. Neuroanat. 2005;30:144&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">16122904</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A., Frisch C., Debeir T., et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp. Neurol. 2007;204:733&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">17306796</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A., Hermann S., Mormann F., et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J. Neuroinflammation. 2008;5:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2553764</ArticleId><ArticleId IdType="pubmed">18793399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler C.N., Gosnell M.S., Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am. J. Respir. Crit. Care Med. 2002;166:1338&#x2013;1344.</Citation><ArticleIdList><ArticleId IdType="pubmed">12421743</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X.N., Niu L.D., Wang Y.J., et al. Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies. J. Neurol. Neurosurg. Psychiatry. 2019;90:590&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">30630955</ArticleId></ArticleIdList></Reference><Reference><Citation>Siciliano M., Trojano L., De Micco R., et al. Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson's disease. J. Neurol. 2021;268:3444&#x2013;3455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357714</ArticleId><ArticleId IdType="pubmed">33723623</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux A., Dugravot A., Brunner E., et al. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology. 2014;83:486&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4141998</ArticleId><ArticleId IdType="pubmed">24991031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparkman N.L., Buchanan J.B., Heyen J.R., Chen J., Beverly J.L., Johnson R.W. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci. 2006;26:10709&#x2013;10716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674759</ArticleId><ArticleId IdType="pubmed">17050710</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y. Cognitive reserve. Neuropsychologia. 2009;47:2015&#x2013;2028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739591</ArticleId><ArticleId IdType="pubmed">19467352</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y., Arenaza-Urquijo E.M., Bartres-Faz D., et al. Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16:1305&#x2013;1311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417987</ArticleId><ArticleId IdType="pubmed">30222945</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gool W.A., van de Beek D., Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet. 2010;375:773&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">20189029</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhage F. Van Gorcum/Prakke &amp; Prakke; Assen, The Netherlands: 1964. Intelligentie en leeftijd onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar [Intelligence and age: Research study in Dutch individuals aged twelve to seventy-seven.</Citation></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser D., Golla S.S.V., Verfaillie S.C.J., et al. Long COVID is associated with extensive &lt;em&gt;in-vivo&lt;/em&gt; neuroinflammation on F18-DPA-714 PET. medRxiv. 2002 2022:2022.2006.</Citation></Reference><Reference><Citation>Wan Y., Xu J., Ma D., Zeng Y., Cibelli M., Maze M. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology. 2007;106:436&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">17325501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J., Jr., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology. 2002;59:371&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">12177370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. Pearson Assessment and Information BV; Amsterdam: 2012. Wechsler adult intelligence scale-fourth edition-nederlandse bewerking. (Technische handleiding en Afname en scorehandleiding).</Citation></Reference><Reference><Citation>Westhoff D., Engelen-Lee J.Y., Hoogland I.C.M., et al. Systemic infection and microglia activation: a prospective postmortem study in sepsis patients. Immun. Ageing. 2019;16:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664744</ArticleId><ArticleId IdType="pubmed">31384283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox M.E., Brummel N.E., Archer K., Ely E.W., Jackson J.C., Hopkins R.O. Cognitive dysfunction in ICU patients: risk factors, predictors, and rehabilitation interventions. Crit. Care Med. 2013;41:S81&#x2013;S98.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters A.E., Slooter A.J., van der Kooi A.W., van Dijk D. Cognitive impairment after intensive care unit admission: a systematic review. Intensive Care Med. 2013;39:376&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">23328935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983;67:361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>